Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
194 Citations•2020•
Shamez Ladhani, Nick Andrews, Sydel R. Parikh
The 4CMenB program was associated with continued positive effect against meningococcal group B disease in children in England, and protection after three doses of the vaccine was sustained for at least 2 years.
Abstract
The 4CMenB program was associated with continued positive effect against meningococcal group B disease in children in England, and protection after three doses of the vaccine was sustained for at least 2 years. (Funded by Public Health England.).